SWX:BCHN
SWX:BCHNMachinery

Burckhardt Compression (SWX:BCHN) Earnings Growth Surpasses 5-Year Trend, Reinforcing Bullish Narratives

Burckhardt Compression Holding (SWX:BCHN) delivered earnings growth of 25.1% over the past year, notably outpacing its five-year average of 22.3% per year. Net profit margins advanced to 9.6% from last year’s 8.7%, and shares now trade at CHF542, still below the analyst fair value estimate of CHF682.96. With high quality earnings and expectations for continued, if slower, growth ahead, investors have plenty of reasons to view the latest results with optimism. However, dividend sustainability...
SWX:SIKA
SWX:SIKAChemicals

Why Sika (SWX:SIKA) Is Down 5.7% After Lower 2025 Results and New Strategic Guidance

In October 2025, Sika AG announced new earnings guidance for 2026–2028, local currency sales growth targets, and reported nine-month 2025 results showing CHF 8,578.1 million in sales and CHF 869.9 million in net income, both lower than the previous year. The past month's developments also included expanding factory operations in Bangladesh and appointing a new General Manager in Romania, reflecting a push for regional growth and leadership transformation. We'll now examine how Sika's new...
SWX:ROG
SWX:ROGPharmaceuticals

Roche Holding (SWX:ROG): Is the Current Valuation Still Compelling After Recent Share Price Swings?

Roche Holding (SWX:ROG) shares have caught the attention of investors following a recent shift in its valuation. With several key metrics offering mixed signals, many are taking a closer look at what is behind these moves. See our latest analysis for Roche Holding. Roche Holding’s share price has seen some turbulence lately, with a 1.73% gain in the last day partly offsetting recent declines, including a 7.95% drop over the past month. Despite short-term choppiness, its total shareholder...
SWX:ABBN
SWX:ABBNElectrical

Assessing ABB's Value Amid Electrification Expansion and 18% Share Price Rise in 2025

Wondering whether ABB might be a bargain or just riding the wave? Here is a breakdown of what the numbers and recent events could mean for anyone curious about the stock’s real value. The stock has seen a strong run, climbing 18.3% year to date and up 177.8% over five years. There has been a slight dip of -2.5% in the past week. Recent news around ABB’s expansion into electrification solutions and investments in automation have powered investor optimism. At the same time, shifting...
SWX:LEHN
SWX:LEHNElectronic

3 European Growth Stocks With High Insider Ownership To Watch

As the European markets experience mixed performances, with the pan-European STOXX Europe 600 Index recently pulling back after reaching fresh highs, investor attention is increasingly turning towards growth companies with high insider ownership. In this environment, stocks that combine robust growth potential and significant insider investment can offer unique insights into confidence levels within a company, making them noteworthy for investors seeking opportunities in a fluctuating market...
SWX:SIKA
SWX:SIKAChemicals

Sika (SWX:SIKA): Evaluating Valuation as New Carbon Footprint Tool Advances ESG Strategy

Sika (SWX:SIKA) has just rolled out the Sika Carbon Compass, an automated tool designed to calculate product carbon footprints. This move aligns with the company’s focus on sustainability and new environmental standards. See our latest analysis for Sika. Even as Sika introduces forward-looking sustainability initiatives, the stock’s momentum has faded, with a 1-year total shareholder return of -36.5%. Recent earnings revealed both sales and profit slid compared to last year, and cautious new...
SWX:ROG
SWX:ROGPharmaceuticals

Roche Stock Slides 9.5% as New Drug Developments Spark Fresh Valuation Debate

Ever find yourself wondering if Roche Holding is a hidden gem or just another pharmaceutical heavyweight trading at a premium? You are not alone. Today we are cutting through the noise to tackle exactly how to think about its value. Despite a recent 3.0% dip over the last week and a 9.5% slide in the past month, Roche Holding is still up 1.1% since the start of the year. This suggests the market is still weighing its long-term prospects against short-term bumps. Recent announcements about...
SWX:NOVN
SWX:NOVNPharmaceuticals

Novartis (SWX:NOVN): Assessing Valuation After Recent Market Movements and Strong Shareholder Returns

Novartis (SWX:NOVN) remains a steady presence in the pharmaceutical sector. Shares closed at 99.5 CHF, reflecting recent market movements that put the stock's performance into perspective for investors watching long-term trends. See our latest analysis for Novartis. Novartis has shown resilient momentum, with the share price pushing upwards nearly 12% year-to-date even after a recent dip. Its total shareholder return over the past three and five years, up 46% and 65% respectively, reflects...